-5 HTP 100 mg 90 capsule DEPRESIE INSOMNII
-5 HTP 100 mg
-90 capsule
-DEPRESIE
-INSOMNII
-5-HTP 98 % (5-Hidroxitriptofan 98 %)
-Produs natural – 100 mg
-Suplimentarea cu 5-HTP reduce efectele unui nivel redus de serotonina in creier.
-Lipsa de serotonina este adesea insotita de simptome precum:
- depresie
- insomnie
- anxietate
- comportament obsesiv
- migrene
- bulimie (tulburare de alimentatie, caracterizata de un consum alimentar excesiv)
- agresivitate
- lipsa de sociabilitate
-In mai multe studii clinice recente, 5-HTP s-a dovedit egal sau chiar superior medicamentelor de sinteza utilizate pentru tratamentul depresiei nervoase.
-Intr-un studiu efectuat in Norvegia s-a demonstrat ca 5-HTP imbunatateste considerabil somnul.
-Studii efectuate in Spania si in Italia au demonstrat ca 5-HTP este eficace contra migrenelor pe fond depresiv.
- 5-HTP este un produs standardizat si concentrat, obtinut din seminte de Griffonia simplicifolia, planta rara din partea de vest a continentului african.
-5-HTP (l-5-Hidroxitriptofan) este o substanta naturala extrasa din semintele plantei medicinale Griffonia simplicifolia.
-5-HTP este un aminoacid precursor al neurotransmitatorului serotonina numita si "substanta fericirii”.
-Vitaminele C si B6 sunt cofactori importanti in bioprocesul de conversie a 5-HTP in serotonina.
- antidepresiv: induce calm, siguranta de sine, relaxare, incredere, dorinta si capacitate de comunicare in depresia reactiva cauzata de un eveniment de viata traumatic, depresia endogena cauzata de dezechilibrele chimice la nivel cerebral, depresia bipolara sau tulburarea maniaco-depresiva, depresia post-partum si tulburarile afective de sezon (depresia de primavara, cauzata de schimbarea luminozitatii ambiante)
- imbunatateste calitatea somnului
- reduce durata si frecventa episoadelor de apnee de somn
- stimuleaza memoria, sustine procesele de invatare, reduce durerile cronice de cap
- adjuvant in curele de slabire (obezitate, bulimie) - regleaza apetitul.
-In timpul curelor de slabire scade nivelul cerebral de serotonina, ceea ce duce la depresie si la nevoia de a consuma dulciuri
- amelioreaza simptomele fibromialgiei, creste pragul durerii
- reduce simptomele in sindromul premenstrual si tulburarile legate de menopauza
- reduce unele forme de dependenta (alcool, tutun, droguri) si comportamentul agresiv
-Instructiuni de folosire:
-Ca supliment alimentar, 1 capsula pe zi
-Doze per flacon:
-90
-Tablete per flacon:
-90
-INGREDIENTE ACTIVE:
-5-HTP 98 % (5-Hidroxitriptofan) (pulbere din extract alcoolic standardizat) din seminte de Griffonia simplicifolia).......100 mg
-Ingrediente inactive:
-gelatina, stearat de magneziu vegetal, faina de Orez
-Prezentare:
-90 de tablete
-Efecte nedorite si contraindicatii:
-Pastrati flaconul intr-un loc uscat, ferit de lumina si exces de caldura si nu-l lasati la indemina si la vederea copiilor mici.
-A nu se administra femeilor insarcinate, precum si acelora care alapteaza.
-Contraindicat in cancer si in prímele doua saptamani de administrare a MAOIs/inhibitori ai monoamin-oxidazei;
-A se administra cu prudenta in caz de:
- episoade ischemice in antecedenta (infarct miocardic, angina pectorala), spasm al arterei coronariene, hipertensiune arteriala.
-Poate interactiona cu antidepresive (serotonina, MAOIs), Hypericum perforatum sau Vitamina B6 la administrare concomitenta.
-Produsul nu este recomandat ca înlocuitor al unui regim alimentar variat si echilibrat si al unui mod de viata sanatos.
-A nu se depasi doza recomandata pentru consumul zilnic.
-Acest produs nu are ca scop sa puna un diagnostic, sa previna, sa trateze sau sa vindece vreo boala.
-Produs USA.
-REFERINTE:
-1: Kovacic P, Somanathan R. Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships. Oxid Med Cell Longev. 2009 Sep-Oct;2(4):181-90. PubMed PMID: 20716904; PubMed Central PMCID: PMC2763256.
-2: Devries MP, Vessalo M, Galligan JJ. Deletion of P2X2 and P2X3 Receptor Subunits Does Not Alter Motility of the Mouse Colon. Front Neurosci. 2010 Mar 19;4:22. PubMed PMID: 20582262; PubMed Central PMCID: PMC2858605.
-3: Devadoss T, Pandey DK, Mahesh R, Yadav SK. Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT(3) receptor antagonist, in animal models of depression. Pharmacol Rep. 2010 Mar-Apr;62(2):245-57. PubMed PMID: 20508279.
-4: Leu-Semenescu S, Arnulf I, Decaix C, Moussa F, Clot F, Boniol C, Touitou Y, Levy R, Vidailhet M, Roze E. Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep. 2010 Mar 1;33(3):307-14. PubMed PMID: 20337188; PubMed Central PMCID: PMC2831424.
-5: Raymond D, Ozelius L. Myoclonus-Dystonia. 2003 May 21 [updated 2005 Dec 19]. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene∂=myo-dystonia PubMed PMID: 20301587.
-6: de Koning-Tijssen MAJ, Rees MI. Hyperekplexia . 2007 Jul 31 [updated 2009 May 19]. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene∂=hyperek
PubMed PMID: 20301437.
-7: Millán-Plano S, Piedrafita E, Miana-Mena FJ, Fuentes-Broto L, Martínez-Ballarín E, López-Pingarrón L, Sáenz MA, García JJ. Melatonin and structurally-related compounds protect synaptosomal membranes from free radical damage. Int J Mol Sci. 2010 Jan 21;11(1):312-28. PubMed PMID: 20162018; PubMed Central PMCID: PMC2821006.
-8: Han Q, Ding H, Robinson H, Christensen BM, Li J. Crystal structure and substrate specificity of Drosophila 3,4-dihydroxyphenylalanine decarboxylase. PLoS One. 2010 Jan 21;5(1):e8826. PubMed PMID: 20098687; PubMed Central PMCID: PMC2809104.
-9: Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit. 2009 Nov;15(11):RA256-62. Review. PubMed PMID: 19865069.
-10: Anderson CM, Jevons M, Thangaraju M, Edwards N, Conlon NJ, Woods S, Ganapathy V, Thwaites DT. Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine. Pharmacol Exp Ther. 2010 Jan;332(1):220-8. Epub 2009 Sep 29. PubMed PMID: 19789362; PubMed Central PMCID: PMC2802479.
-11: Drozdov I, Kidd M, Gustafsson BI, Svejda B, Joseph R, Pfragner R, Modlin IM. Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines. Cancer. 2009 Nov 1;115(21):4934-45. PubMed PMID: 19634160; PubMed Central PMCID: PMC2767432.
-12: Shin EJ, Jeong JH, Chung YH, Kim TW, Shin CY, Kim WK, Ko KH, Kim HC. Decrease in the kainate-induced wet dog shake behavior in genetically epilepsy-prone rats: possible involvement of an impaired synaptic transmission to the 5-HT(2A) receptor. J Pharmacol Sci. 2009 Jul;110(3):401-4. PubMed PMID: 19609070.
-13: Zhao H, Sagert J, Hwang DS, Waite JH. Glycosylated hydroxytryptophan in a mussel adhesive protein from Perna viridis. J Biol Chem. 2009 Aug 28;284(35):23344-52. Epub 2009 Jul 7. PubMed PMID: 19584055; PubMed Central PMCID: PMC2749108.
-14: Trachte GJ, Uncini T, Hinz M. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population. Neuropsychiatr Dis Treat. 2009;5:227-35. Epub 2009 May 20. PubMed PMID: 19557117; PubMed Central PMCID: PMC2695216.
-15: Zhang G, Krishnamoorthy S, Ma Z, Vukovich NP, Huang X, Tao R. Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome. Eur J Pharmacol. 2009 Aug 1;615(1-3):66-75. Epub 2009 May 20. PubMed PMID: 19464285; PubMed Central PMCID: PMC2756783.
-16: Lorenzi V, Carpenter RE, Summers CH, Earley RL, Grober MS. Serotonin, social status and sex change in the bluebanded goby Lythrypnus dalli. Physiol Behav. 2009 Jun 22;97(3-4):476-83. Epub 2009 Apr 2. PubMed PMID: 19345236; PubMed Central PMCID: PMC2683889.
-17: Chae HS, Kang OH, Choi JG, Oh YC, Lee YS, Jang HJ, Kim JH, Park H, Jung KY, Sohn DH, Kwon DY. 5-hydroxytryptophan acts on the mitogen-activated protein kinase extracellular-signal regulated protein kinase pathway to modulate cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 cells. Biol Pharm Bull. 2009 Apr;32(4):553-7. PubMed PMID: 19336883.
-18: Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring). 2009 Sep;17(9):1730-5. Epub 2009 Mar 19. PubMed PMID: 19300434.
-19: Fox MA, Jensen CL, Murphy DL. Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice. Int JNeuropsychopharmacol. 2009 Sep;12(8):1055-65. Epub 2009 Mar 11. PubMed PMID: 19275775; PubMed Central PMCID: PMC2750095.
|
